Boston – September 14, 2016 – Donna LaVoie, president and CEO of LaVoieHealthScience (LHS), an award winning strategic communications agency focused on health and life science, will be a featured speaker on Wednesday, September 14, at the BioPharm America’s 9th Annual International Partnering Conference to be held in Boston.
BioPharm America provides a unique venue for hundreds of the world’s most innovative leaders across the biotech, finance, and pharma industries to participate in high-level networking and partnering meetings.
LaVoie’s workshop, titled Corporate Governance: When to Build a Board and How to Select Your Members, is part of Biotech Startup Day, designed for emerging companies to explore leadership, operations and pathways to commercialization.
The presentation is focused on corporate governance, providing insight about the purpose of a board, the appropriate timing and insight into selecting the right members. As the CEO of a leading business and her background in life science, LaVoie will offer expert guidance on the importance of complimenting business fundamentals with scientific expertise, as well as the appropriate resources to ensure a strong board.
Produced by the EBD group, BioPharm America is an exclusive life science partnering event of the year, fostering the right partners to participate in pre-scheduled meetings, informal networking, and strategic panel discussions.
LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital, and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations to improve humankind. The agency has received 28 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients. The agency ranks among the 2016 Inc. 5000 list of fastest growing private companies.
Vice President, Investor Relations